In observance of ancient traditions, we will take a break over the next two days, and return next week. We recognize that the world will continue spinning in our absence, but assure you that we will be back soon enough to resume the daily dose of news, views and chatter that turns you on. Until then, we wish you the best.
Pfizer Faces New Competitive Threat To Chantix (Financial Times)
Can Open Access R&D Cure Industry Woes? (Reuters)
Number Of US Kids On ADHD Meds Keeps Rising (HealthDay)
Bayer Wins End To Yaz Antitrust Lawsuit (Reuters)
Recession Causes 'Risky Prescription Drug Practices' (Pharma Times)
Pfizer Says Buying Indian Pharma Will Not Lead To Price Hikes (Economic Times)